EMN
62
-3
NKE
43
-6
CSCO
60
-4
MA
55
2
MOS
50
8
BF.B
59
-2
AAP
12
-14
CMI
72
-5
MNST
51
2
FDX
53
-2
BK
74
-5
KO
46
5
HPE
64
-5
CPB
39
2
FITB
76
-4
EMR
65
-8
STT
73
-4
HP
42
-7
COF
65
-3
ED
39
3
EMN
62
-3
NKE
43
-6
CSCO
60
-4
MA
55
2
MOS
50
8
BF.B
59
-2
AAP
12
-14
CMI
72
-5
MNST
51
2
FDX
53
-2
BK
74
-5
KO
46
5
HPE
64
-5
CPB
39
2
FITB
76
-4
EMR
65
-8
STT
73
-4
HP
42
-7
COF
65
-3
ED
39
3
Financhill
Back

Desjardins RI USA - Net-Zero Emissions Pathway ETF Vs. MiNK Therapeutics, Inc. Industry Stock Comparison

Sell
40

DRMU.TO
Desjardins RI USA - Net-Zero Emissions Pathway ETF

Last Price:
$49.91
Seasonality Move:
6.74%
Sell
39

INKT
MiNK Therapeutics, Inc.

Last Price:
$12.42
Seasonality Move:
-18.07%
Sell
40
Desjardins RI USA - Net-Zero Emissions Pathway ETF (DRMU.TO) is a Sell

Is Desjardins RI USA - Net-Zero Emissions Pathway ETF a Buy, Sell or Hold?

  • The current Desjardins RI USA - Net-Zero Emissions Pathway ETF [DRMU.TO] share price is $49.91. The Score for DRMU.TO is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • DRMU.TO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
MiNK Therapeutics, Inc. (INKT) is a Sell

Is MiNK Therapeutics, Inc. a Buy, Sell or Hold?

  • The current MiNK Therapeutics, Inc. [INKT] share price is $12.42. The Score for INKT is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • INKT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

DRMU.TO Stock Price Chart

What is Desjardins RI USA - Net-Zero Emissions Pathway ETF's stock price today?

  • The Desjardins RI USA - Net-Zero Emissions Pathway ETF share price today is $49.91
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DRMU.TO is experiencing selling pressure, which indicates risk of future bearish movement.

INKT Stock Price Chart

What is MiNK Therapeutics, Inc.'s stock price today?

  • The MiNK Therapeutics, Inc. share price today is $12.42
    The current trend is relatively stagnant and INKT is experiencing slight selling pressure.

DRMU.TO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.05 Buy
Relative Strength Index (14 RSI): 43.57 Sell
Chaikin Money Flow: -1202 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.75 - 50.89) Sell
Bollinger Bands (100): (47.42 - 50.52) Buy

INKT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.15 Sell
Relative Strength Index (14 RSI): 51.41 Buy
Chaikin Money Flow: -4658 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.9 - 13.02) Buy
Bollinger Bands (100): (12.31 - 15.67) Sell

DRMU.TO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 50.47 Sell
20-day SMA: 50.26 Sell
50-day SMA: 50.28 Sell
200-day SMA: 45.98 Buy
8-day EMA: 50.37 Sell
20-day EMA: 50.38 Sell
50-day EMA: 49.99 Sell
200-day EMA: 47.03 Buy

INKT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 12.19 Buy
20-day SMA: 11.57 Buy
50-day SMA: 13.1 Sell
200-day SMA: 11.81 Buy
8-day EMA: 12.21 Buy
20-day EMA: 12.1 Buy
50-day EMA: 12.78 Sell
200-day EMA: 12.24 Buy

Desjardins RI USA - Net-Zero Emissions Pathway ETF Earnings Growth & DRMU.TO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

MiNK Therapeutics, Inc. Earnings Growth & INKT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.40 per share, and a decrease next year of $0.82 per share.

Desjardins RI USA - Net-Zero Emissions Pathway ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

MiNK Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):